Page 160 - 70_03
P. 160

JOSÉ LUIS PEDRAZ y GORKA ORIVE  AN. R. ACAD. NAC. FARM.

      BIBLIOGRAFÍA

 (1)  ORIVE, G.; HERNÁNDEZ, R.M.; GASCÓN, A.R.; IGARTUA, M.; PEDRAZ, J.L. (2003) Cell
 (2)  encapsulation technology for biomedical purposes: novel insights and cha-
 (3)  llenges. Trends Pharm. Sci. 24, 207-210.
 (4)  ORIVE, G.; HERNÁNDEZ, R.M.; GASCÓN, A.R.; CALAFIORE, R.; CHANG, T.M.S.; DE
 (5)  VOS, P.; HORTELANO, G.; HUNKELER, D.; LACÍK, I.; SHAPIRO, A.M.J.; PEDRAZ, J.L.
 (6)  (2003) Cell encapsulation: promise and progress. Nat. Med. 9, 104-107.
 (7)  BISCEGLIE, V. (1933) Uber die antineoplastische immunitat; heterologe Ein-
 (8)  planzung von tumoren in Huhner-embryonen. Ztschr. Krebsforsch. 40: 45-58.
      ALGIRE, G.H. (1943) An adaptation of the transparent chamber technique to
 (9)  the mouse. J. Natl. Cancer Inst., 4: 1-11.
(10)  ANGELOVA, N.; HUNKELER, D. (1999) Rationalizing the design of polymeric bio-
(11)  materials. Trends Biotechnol. 17, 409-421.
(12)  HUNKELER, D.; SUN, A.M.; KORBUTT, G.S.; RAJOTTE, R.V.; GILL, R.G.; CALAFIORE,
      R.; MOREL, P. (1999) Bioartificial organs and acceptable risk. Nat. Biotechnol.
(13)  17, 1045.
(14)  HUNKELER, D. (2000) Objectively assessing bioartificial organs. Nat. Biotech-
(15)  nol. 18, 1021.
      ORIVE, G.; HERNÁNDEZ, R.M.; GASCÓN, A.R.; CALAFIORE, R.; CHANG, T.M.S.; DE
      VOS, P.; HORTELANO, G.; HUNKELER, D.; LACÍK, I.; PEDRAZ, J.L. (2004) History,
      challenges and promises of cell microencapsulation. Trends Biotechnol. 22,
      87-92.
      SOON-SHIONG, P.; HEINTZ, R.; MERIDETH, N.; YAO QUIANG, X.; YAO, Z.; ZHENG, T.
      (1994) Insulin independence in a type I diabetic patient after encapsulated
      islet transplantation. Lancet 343, 950-951.
      DE VOS, P.; HAMEL, A.F.; TATARKIEWICZ, K. (2002) Considerations for successful
      transplantation of encapsulated pancreatic islets. Diabetologia 45, 159-173.
      TSENG, J.L.; BAETGE, E.E.; ZURN, A.D.; AEBISCHER, P. (1997) GDNF reduces
      drug-induced rotational behaviour after medial forebrain bundle transection
      by a mechanism not involving striatal dopamine. J. Neurosci. 17, 325-333.
      EMERICH, D.F.; WINN, S.R.; HANTRAYE, P.M.; PESCHANSKI, M.; CHEN, E.Y.; CHU,
      Y.; MCDERMOTT, P.; BAETGE, E.E.; KORDOWER, J.H. (1997) Protective effect of
      encapsulated cells producing neurotrophic factor CNTF in a monkey model
      of Huntington’s disease. Nature, Vol. 386, 395-399.
      LÖRH, M.; HOFFMEYER, A.; KRÖGER, J.C.; FREUND, M.; HAIN, J.; HOLLE, A. (2001)
      Microencapsulated cell-mediated treatment of inoperable pancreatic carci-
      noma. Lancet 357, 1591-1592.
      CIRONE, P.; BOURGEOIS, M.; AUSTIN, R.C.; CHANG, P.L. (2002) A novel approach
      to tumor suppression with microencapsulated recombinant cells. Hum. Gene.
      Ther. 13, 1157-1166.
      ORIVE, G.; HERNÁNDEZ, R.M.; GASCÓN, A.R.; IGARTUA, M.; ROJAS, A.; PEDRAZ, J.L.
      (2001) Microencapsulation of an anti VE-cadherin antibody secreting 1B5
      hybridoma cells. Biotechnol. Bioeng. 76, 285-294.

786
   155   156   157   158   159   160   161   162   163   164   165